- Home
- ARDX vs VMEO Comparison
ARDX vs VMEO Comparison
Compare ARDX & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- VMEO
- Stock Information
- Founded
- ARDX 2007
- VMEO 2004
- Country
- ARDX United States
- VMEO United States
- Employees
- ARDX N/A
- VMEO N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- VMEO Computer Software: Prepackaged Software
- Sector
- ARDX Health Care
- VMEO Technology
- Exchange
- ARDX Nasdaq
- VMEO Nasdaq
- Market Cap
- ARDX 1.2B
- VMEO 1.1B
- IPO Year
- ARDX 2014
- VMEO N/A
- Fundamental
- Price
- ARDX $4.91
- VMEO $6.35
- Analyst Decision
- ARDX Buy
- VMEO Buy
- Analyst Count
- ARDX 7
- VMEO 3
- Target Price
- ARDX $10.58
- VMEO $8.67
- AVG Volume (30 Days)
- ARDX 5.0M
- VMEO 1.4M
- Earning Date
- ARDX 02-20-2025
- VMEO 02-19-2025
- Dividend Yield
- ARDX N/A
- VMEO N/A
- EPS Growth
- ARDX N/A
- VMEO 290.90
- EPS
- ARDX N/A
- VMEO 0.20
- Revenue
- ARDX $251,849,000.00
- VMEO $419,394,000.00
- Revenue This Year
- ARDX $168.07
- VMEO $1.32
- Revenue Next Year
- ARDX $16.66
- VMEO $2.07
- P/E Ratio
- ARDX N/A
- VMEO $32.05
- Revenue Growth
- ARDX 87.57
- VMEO 0.52
- 52 Week Low
- ARDX $4.32
- VMEO $3.43
- 52 Week High
- ARDX $10.13
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- ARDX 44.85
- VMEO 46.89
- Support Level
- ARDX $4.98
- VMEO $5.91
- Resistance Level
- ARDX $6.07
- VMEO $6.45
- Average True Range (ATR)
- ARDX 0.37
- VMEO 0.24
- MACD
- ARDX -0.01
- VMEO -0.03
- Stochastic Oscillator
- ARDX 4.92
- VMEO 42.31
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.